Elanco Animal Health Inc financial data

Symbol
ELAN on NYSE
Industry
Pharmaceutical Preparations
Location
2500 Innovation Way, Greenfield, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 287 % +19.2%
Quick Ratio 128 % +14.6%
Debt-to-equity 124 % +6.18%
Return On Equity 3.31 %
Return On Assets 1.48 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 494M shares +0.32%
Common Stock, Shares, Outstanding 494M shares +0.34%
Entity Public Float 4.9B USD -47.3%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 494M shares +0.33%
Weighted Average Number of Shares Outstanding, Diluted 498M shares +1.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.45B USD +2.02%
Research and Development Expense 342M USD +4.27%
Costs and Expenses 4.04B USD -26.8%
Nonoperating Income (Expense) -46M USD +25.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 412M USD
Income Tax Expense (Benefit) 207M USD
Net Income (Loss) Attributable to Parent 205M USD
Earnings Per Share, Basic 0.41 USD/shares
Earnings Per Share, Diluted 0.4 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 490M USD +32.8%
Accounts Receivable, after Allowance for Credit Loss, Current 840M USD -7.79%
Inventory, Net 1.63B USD -3.43%
Assets, Current 3.37B USD -5.58%
Property, Plant and Equipment, Net 979M USD -1.31%
Operating Lease, Right-of-Use Asset 140M USD -0.71%
Intangible Assets, Net (Excluding Goodwill) 4.01B USD -10.4%
Goodwill 4.63B USD -5.65%
Other Assets, Noncurrent 302M USD -26.3%
Assets 13.3B USD -7.4%
Accounts Payable, Current 259M USD -12.5%
Employee-related Liabilities, Current 157M USD +7.53%
Contract with Customer, Liability, Current 333M USD -6.46%
Liabilities, Current 1.32B USD +4.43%
Deferred Income Tax Liabilities, Net 539M USD -16.2%
Operating Lease, Liability, Noncurrent 110M USD -0.9%
Other Liabilities, Noncurrent 587M USD +35.9%
Liabilities 6.76B USD -17.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -339M USD +29.7%
Retained Earnings (Accumulated Deficit) -1.94B USD +9.55%
Stockholders' Equity Attributable to Parent 6.52B USD +6.34%
Liabilities and Equity 13.3B USD -7.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2M USD
Net Cash Provided by (Used in) Financing Activities -27M USD -116%
Net Cash Provided by (Used in) Investing Activities 37M USD
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 494M shares +0.34%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7M USD +74.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 490M USD +32.8%
Deferred Tax Assets, Valuation Allowance 363M USD +59.2%
Deferred Tax Assets, Gross 815M USD +13.2%
Operating Lease, Liability 142M USD 0%
Payments to Acquire Property, Plant, and Equipment 24M USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 348M USD
Lessee, Operating Lease, Liability, to be Paid 164M USD 0%
Property, Plant and Equipment, Gross 1.84B USD +6.91%
Operating Lease, Liability, Current 32M USD +3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30M USD +7.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 39M USD +8.33%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25%
Deferred Income Tax Expense (Benefit) 2M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 25M USD +13.6%
Deferred Tax Assets, Operating Loss Carryforwards 314M USD -4.56%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 31M USD +93.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16M USD -5.88%
Additional Paid in Capital 8.8B USD +0.47%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 535M USD -0.93%
Depreciation, Depletion and Amortization 166M USD -4.05%
Deferred Tax Assets, Net of Valuation Allowance 452M USD -8.13%
Interest Expense 256M USD -5.88%